FIELD: pharmacology, in particular pharmaceutical composition for obesity prophylaxis and treatment.
SUBSTANCE: invention relates to claimed composition containing crystalline sibutramine methanesulfonate hemihydrate, as well as methods for production and uses of crystalline sibutramine methanesulfonate hemihydrate.
EFFECT: product with improved solubility.
12 cl, 5 dwg, 5 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SALT AND POLYMORPH OF A PHENYL-PYRIMIDONE COMPOUND, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | 2018 |
|
RU2761213C2 |
| NOVEL COMPLEX OF AGOMELATINE AND SULFONIC ACID, SYNTHESIS METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | 2014 |
|
RU2673080C2 |
| PAROXETINE CHOLATE OR SALTS OF CHOLIC ACID DERIVATIVES AND COMPOSITION CONTAINING PAROXETINE AND CHOLIC ACID OR CHOLIC ACID DERIVATIVES | 2004 |
|
RU2337919C2 |
| METHOD OF PRODUCING A THIAZOLE DERIVATIVE | 2016 |
|
RU2738937C2 |
| (S)-(-)-AMLODIPINE CAMSYLATE OR ITS HYDRATE AND PHARMACEUTICAL COMPOSITION INCLUDING THEM | 2007 |
|
RU2403241C1 |
| CRYSTALLINE CLOPIDOGREL NAPHTALENE SULFONATE OR ITS HYDRATE, METHODS FOR ITS PRODUCING AND PHARMACEUTICAL COMPOSITION | 2004 |
|
RU2328501C1 |
| PHENYL AMINO PYRIMIDINE COMPOUND OR POLYMORPH OF SALT THEREOF | 2016 |
|
RU2712226C2 |
| DERIVATIVES OF 6-METHOXY-1H-BENZOTRIAZOLE-5-CARBOXAMIDE, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF | 1995 |
|
RU2141958C1 |
| CRYSTALLINE AND SALT FORMS OF THE TGF-βR1 INHIBITOR AND THE METHOD OF OBTAINING THEM | 2018 |
|
RU2750702C1 |
| BIARYL- OR HETEROCYCLIC BIARYL-SUBSTITUTED DERIVATIVES OF CYCLOHEXENE AS CETP INHIBITORS | 2014 |
|
RU2627361C2 |
